Claims for Patent: 7,807,370

Summary for Patent: 7,807,370

Title:	Methods for identification of merle gene
Abstract:	Animals with mutations in SILV present with the merle coat color pattern phenotype. Methods for the identification of animals that harbor a mutation in the SILV gene are described. Mutations in the SILV gene can be identified from any biological sample such as a cell or tissue that contains genomic DNA. A microsatellite marker identified using linkage disequilibrium mapping that segregates with merle is also described.
Inventor(s):	Murphy; Keith E. (College Station, TX), Clark; Leigh Anne (College Station, TX), Wahl; Jacquelyn (Snook, TX), Rees; Christine (Magnolia, TX)
Assignee:	Merlogen, LLC (Clemson, SC)
Application Number:	12/063,964
Patent Claims:	1. A method for identifying a merle and/or a cryptic merle allele in a canine animal, the method comprising: analyzing a biological sample obtained from the canine animal for mutations in the SILV gene, wherein the presence of at least one insertion mutation at the boundary of intron 10 and exon 11 of the SILV gene indicates the canine animal has a merle or a cryptic merle allele, wherein the insertion comprises a short interspersed nucleotide element (SINE). 2. The method of claim 1, wherein the insertion is present between nucleotide positions corresponding to positions 43 and 44 of SEQ ID NO:24. 3. The method of claim 1, wherein the insertion is flanked by the first 15 nucleotides of any one of SEQ ID NOs:26-36. 4. The method of claim 1, wherein the merle allele is cryptic if the length of the poly-A segment of the SINE element is reduced by about 30 nucleotides relative to the length of any of the poly-A segments corresponding to the poly-T segments of the SINE elements shown in SEQ ID NOs:26-33. 5. The method of claim 1, wherein the canine animal is a dog. 6. The method of claim 1, wherein the canine animal has a merle allele. 7. The method of claim 6, wherein the merle allele comprises any one of SEQ ID NOs:26-33. 8. The method of claim 1, wherein the canine animal has a cryptic merle allele. 9. The method of claim 8, wherein the cryptic merle allele is SEQ ID NO: 34, 35 or 36. 10. The method of claim 1, wherein the biological sample is cell or tissue containing genomic DNA obtained from a dog. 11. The method of claim 1, wherein the biological sample is analyzed by performing PCR using genomic DNA as a template.

Details for Patent 7,807,370

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2025-08-16
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2025-08-16
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2025-08-16